...
首页> 外文期刊>Circulation research: a journal of the American Heart Association >Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemia-reperfusion injury in Mice
【24h】

Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemia-reperfusion injury in Mice

机译:基因对心肌细胞中蛋白酶体的中度抑制加剧了小鼠的心肌缺血-再灌注损伤

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Rationale: Both cardiomyocyte-restricted proteasome functional enhancement and pharmacological proteasome inhibition (PSMI) were shown to attenuate myocardial ischemia/reperfusion (I/R) injury. The role of cardiac proteasome dysfunction during I/R and the perspective to diminish I/R injury by manipulating proteasome function remain unclear. Objectives: We sought to determine proteasome adequacy in I/R hearts, create a mouse model of cardiomyocyte-restricted PSMI (CR-PSMI), and test CR-PSMI impact on I/R injury. Methods and Results: Myocardial I/R were modeled by ligation (30 minutes) and subsequent release of the left anterior descending artery in mice overexpressing GFPdgn, a validated surrogate proteasome substrate. At 24 hours of reperfusion, myocardial proteasome activities were significantly lower whereas total ubiquitin conjugates and GFPdgn protein levels were markedly higher in all regions of the I/R hearts than the sham controls, indicative of proteasome functional insufficiency. CR-PSMI in intact mice was achieved by transgenic (tg) overexpression of a peptidase-disabled mouse β5 subunit (T60A-β5) driven by an attenuated mouse mhc6 promoter. Overexpressed T60A-β5 can replace endogenous β5 and inhibits proteasome chymotrypsin-like activities in the heart. Mice with moderate CR-PSMI showed no abnormalities at the baseline but displayed markedly more pronounced structural and functional damage during I/R, compared with non-tg littermates. The exacerbation of I/R injury by moderate CR-PSMI was associated with significant increases in the protein level of PTEN and protein kinase Cδ (PKCδ), decreased Akt activation, and reduced PKC[Latin Small Letter Open E]. Conclusions: Myocardial I/R causes proteasome functional insufficiency in cardiomyocytes and moderate CR-PSMI augments PTEN and PKCδ, suppresses Akt and PKC[Latin Small Letter Open E], increases cardiomyocyte apoptosis, and aggravates I/R injury in mice.
机译:原理:心肌细胞限制的蛋白酶体功能增强和药理学的蛋白酶体抑制(PSMI)均能减轻心肌缺血/再灌注(I / R)损伤。心脏蛋白酶体功能障碍在I / R期间的作用以及通过操纵蛋白酶体功能来减轻I / R损伤的观点尚不清楚。目的:我们试图确定I / R心脏中的蛋白酶体充足性,创建心肌细胞限制性PSMI(CR-PSMI)的小鼠模型,并测试CR-PSMI对I / R损伤的影响。方法和结果:通过结扎(30分钟)和随后释放过表达GFPdgn(一种经过验证的替代蛋白酶体底物)的小鼠左前降支动脉建立心肌I / R模型。在再灌注24小时后,I / R心脏所有区域的心肌蛋白酶体活性均显着降低,而总泛素结合物和GFPdgn蛋白水平显着高于假对照组,表明蛋白酶体功能不足。完整小鼠中的CR-PSMI是通过转基因(tg)过表达由减毒小鼠mhc6启动子驱动的肽酶禁用的小鼠β5亚基(T60A-β5)来实现的。过表达的T60A-β5可以替代内源性β5,并抑制心脏中的蛋白酶体胰凝乳蛋白酶样活性。与非tg同窝仔相比,具有中等CR-PSMI的小鼠在基线时未显示异常,但在I / R期间显示出明显更明显的结构和功能损伤。中度CR-PSMI加重I / R损伤与PTEN和蛋白激酶Cδ(PKCδ)的蛋白水平显着升高,Akt激活降低和PKC降低有关[拉丁文小写字母E]。结论:心肌I / R导致心肌细胞蛋白酶体功能不足,中度CR-PSMI增强PTEN和PKCδ,抑制Akt和PKC [拉丁文小写字母E],增加心肌细胞凋亡,并加重小鼠I / R损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号